Table 4.

Occurrence of side effects derived from a checklist during follow-up

	Sertraline	Placebo
	(N=66)	(N=63)	Sertraline vs Placebo
			Unadjusted OR	95% CI	p- value (Exact)
Agitation	38	46	0.50	(0.22, 1,12)	0.10
Anxiety	54	53	0.85	(0.30, 2.36)	0.82
Confusion	38	36	1.02	(0.48, 2.17)	1.00
Constipation	22	18	1.25	(0.55, 2.84)	0.57
Decreased Libido	10	7	1.42	(0.45, 4.75)	0.61
Diarrhea	34	19	2.44	(1.13, 5.42)	0.02
Dizziness	39	19	3.31	(1.52, 7.41)	0.001
Drug allergy	4	0	--	--	0.12
Dry mouth	30	17	2.24	(1.02, 5.07)	0.04
Ejaculatory dysfunction	7	6	1.13	(0.30, 4.32)	1.00
Falls	16	11	1.51	(0.59, 3.97)	0.39
Fatigue	53	50	1.06	(0.41, 2.75)	1.00
Gait instability	35	31	1.16	(0.55, 2.46)	0.73
Headache	29	22	1.46	(0.68, 3.16)	0.37
Indigestion	23	11	2.51	(1.04, 6,39)	0.03
Insomnia	32	32	0.91	(0.43, 1.93)	0.87
Nausea	15	8	2.01	(0.73, 5.97)	0.17
Nervousness	37	35	1.02	(0.48, 2.17)	1.00
Poor Appetite	29	28	0.98	(0.46, 2.08)	1.00
Somnolence	35	32	1.09	(0.52, 2.31)	0.91
Tremor	23	15	1.70	(0.74, 4.00)	0.18
Visual Disturbance	14	13	1.04	(0.41, 2.66)	1.00
Vomiting	11	4	2.93	(0.81, 13.35)	0.10
Other Symptoms	32	35	0.75	(0.36, 1.59)	0.48

Fisher’s exact test used to calculate the p-values.